Your browser doesn't support javascript.
loading
Camrelizumab plus apatinib successfully treated a patient with advanced esophageal squamous cell carcinoma.
Yan, Zheng; Yao, Zhi-Hua; Yao, Shu-Na; Wang, Hai-Ying; Chu, Jun-Feng; Song, Ming; Zhao, Shuang; Liu, Yan-Yan.
Afiliação
  • Yan Z; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, 27 Dongming Road, Zhengzhou, Henan 450008, China.
  • Yao ZH; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, 27 Dongming Road, Zhengzhou, Henan 450008, China.
  • Yao SN; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, 27 Dongming Road, Zhengzhou, Henan 450008, China.
  • Wang HY; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, 27 Dongming Road, Zhengzhou, Henan 450008, China.
  • Chu JF; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, 27 Dongming Road, Zhengzhou, Henan 450008, China.
  • Song M; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, 27 Dongming Road, Zhengzhou, Henan 450008, China.
  • Zhao S; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, 27 Dongming Road, Zhengzhou, Henan 450008, China.
  • Liu YY; Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, 27 Dongming Road, Zhengzhou, Henan 450008, China.
Immunotherapy ; 12(16): 1161-1166, 2020 11.
Article em En | MEDLINE | ID: mdl-32814482

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias Esofágicas / Anticorpos Monoclonais Humanizados / Carcinoma de Células Escamosas do Esôfago / Imunoterapia / Antineoplásicos Limite: Humans / Male / Middle aged Idioma: En Revista: Immunotherapy Assunto da revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias Esofágicas / Anticorpos Monoclonais Humanizados / Carcinoma de Células Escamosas do Esôfago / Imunoterapia / Antineoplásicos Limite: Humans / Male / Middle aged Idioma: En Revista: Immunotherapy Assunto da revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido